'Will roll out vaccine as early as possible': Bharat Biotech on COVAXIN

Video Credit: ANI
Published on January 4, 2021 - Duration: 01:12s

'Will roll out vaccine as early as possible': Bharat Biotech on COVAXIN

While addressing a press conference via video conferencing in Hyderabad on January 04, the Chairman and Managing Director (MD) of Bharat Biotech International Limited, Dr Krishna M Ella explained meaning of the phrase 'restricted use in emergency situation in clinical trial mode'.

Ella said, "No placebo.

We keep vaccinating the people at an open level and then monitor the safety and efficacy.

That is what it means in our project mode method in emergency license." "We will roll out the vaccine as early as possible.

Batches have been sent to Kasauli government testing lab already."


You are here


💡 newsR Knowledge: Other News Mentions

Related news from verified sources

India’s drugs regulator DCGI on January 3 approved Oxford’s COVID-19 vaccine Covishield and Bharat Biotech’s Covaxin for restricted emergency use
on January 3, 2021 • Hindu

The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the...
on January 3, 2021 • Mid-Day

India's vaccine rollout will begin with the availability of two jabs- Oxford-Astra Zeneca's Covishield and Bharat Biotech's homegrown Covaxin- with the Drugs...
on January 2, 2021 • IndiaTimes

Related videos from verified sources

Healthcare workers should be given choice in vaccines: Karnataka resident doctors 01:30
Video credit: ANI - Published on January 19, 2021 

India's Covid cases drop to lowest in 7 months, vaccination drive day 4|Oneindia News 02:26
Video credit: Oneindia - Published on January 19, 2021 

Covaxin: Do not inject if you have these conditions | Oneindia News 01:08
Video credit: Oneindia - Published on January 19, 2021 

You might like